SUPPORT-E

Supporting high quality evaluation of CCP throughout Europe

About

The SUPPORT-E project focuses on utilization of plasma from COVID-19 convalescent patients (CCP) as potential curative strategy, particularly to immune-compromised patients. Read more: https://www.support-e.eu/

Project duration: 07.2020 – 06.2022 extended through amendment until 06/2023

 Project Aims: The main goal of the SUPPORT-E project is to provide support to high quality clinical evaluation of COVID-19 Convalescent Plasma (CCP). After an accurate analysis of the data collected also through the EU-CCP database, SUPPORT-E team will proceed to achieve a consensus on the appropriate use of CCP in the treatment of COVID-19 across Europe.

Expected outcomes: This project hopes to share its findings on the effectiveness of CCP as a therapeutic option to tackle COVID-19 and put forward evidence-based recommendations to be applicable throughout Europe in the current and potential epidemiological outbreaks.

Project partners

1. European Blood Alliance – Belgium (The Netherlands in the GA)
2. Etablissement Francais du Sang – France
3. DRK-Blutspendedienst – Baden Wurttemberg Hessen – Germany
4. Stichting Sanquin Bloedvoorzienning – The Netherlands
5. Belgische Rode Kruis – Belgium
6. Aarhus Universitetshospital – Denmark
7. Instituto Superiore di Sanita – Italy
8. Fondazione IRCCS Policlinico San Matteo – Italy
9. Azienda Socio Sanitaria Teritoriale di Mantova (Asst di Mantova) – Italy
10. NHS Blood and Transplant – UK
11. Statens Serum Institut – Denmark
12. Blutspende SRK Schweiz AG – Switzerland